Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10751333 | AZURITY | Compositions and kits for omeprazole suspension |
Jul, 2039
(15 years from now) | |
US11103492 | AZURITY | Compositions and kits for omeprazole suspension |
Jul, 2039
(15 years from now) | |
US11633478 | AZURITY | Compositions and kits for Omeprazole suspension |
Jul, 2039
(15 years from now) | |
US11771686 | AZURITY | Compositions and kits for omeprazole suspension |
Mar, 2040
(15 years from now) |
Market Authorisation Date: 30 August, 2022
Treatment: Short term treatment of active benign gastric ulcer
Dosage: FOR SUSPENSION;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
US6780882 | SALIX | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) | |
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
USRE45198 | SALIX | Omeprazole solution and method for using same |
Jul, 2016
(7 years ago) | |
US7399772 | SALIX | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) | |
US5840737 | SALIX | Omeprazole solution and method for using same |
Jul, 2016
(7 years ago) | |
US6645988 | SALIX | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) | |
US6699885 | SALIX | Substituted benzimidazole dosage forms and methods of using same |
Jul, 2016
(7 years ago) | |
US6489346 | SALIX | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) |
Market Authorisation Date: 15 June, 2004
Treatment: Short-term treatment of active duodenal ulcer; Treatment of heartburn and other symptoms associated with gerd; Short-term treatment of erosive esophagitis; Maintenance of healing of erosive esophagiti...
Dosage: FOR SUSPENSION;ORAL; CAPSULE;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7399772 | RILEY CONSUMER | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) | |
US6699885 | RILEY CONSUMER | Substituted benzimidazole dosage forms and methods of using same |
Jul, 2016
(7 years ago) | |
US6645988 | RILEY CONSUMER | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) | |
US5840737 | RILEY CONSUMER | Omeprazole solution and method for using same |
Jul, 2016
(7 years ago) | |
US6780882 | RILEY CONSUMER | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) | |
US6489346 | RILEY CONSUMER | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) |
Market Authorisation Date: 01 December, 2009
Treatment: Treating frequent heartburn
Dosage: CAPSULE;ORAL; FOR SUSPENSION;ORAL